ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Concord Biotech Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory compliance disclosure under SEBI LODR.
Concord Biotech confirmed the successful completion of the ANVISA inspection at its Limbasi API plant. This strengthens its regulatory standing and supports global expansion.
Concord Biotech Limited submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that no dematerialization or rematerialization requests were received during this period.